Table 2 Effects of Loco-regional treatment on tumor growth in mouse models of hepatocellular carcinoma
From: An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma
Study model | Treatment | Effects on tumor | Reference |
|---|---|---|---|
HepG2/ADM human hepatoma mouse model | nHAPs, rmhTNF-alpha, ADM, mitomycin, 5-FU | Tumor growth reduction | [52] |
GPC3-negative colorectal adenocarcinoma mouse model | Glypican-3, RFA | Tumor growth reduction | |
HCCLM3 mouse model | nsPEF | Tumor growth reduction | |
Hep3B xenograft mouse model | 5 Gold nanoparticles, RF | Tumor growth reduction | [56] |